At Azalium Pharmaceutical, our R&D division serves as the engine of scientific discovery, formulation innovation, and regulatory compliance. Operating from state-of-the-art facilities in Hyderabad, India, our research teams specialize in advanced formulation development, analytical method validation, and complex API synthesis.
Multidisciplinary experts in formulation & analytical chemistry
Intellectual property across key therapeutic domains
Equipped with HPLC, LC-MS/MS, GC, and FTIR testing systems
Strict alignment with US FDA, EMA, and WHO cGMP standards
Designing robust, stable, and bio-equivalent dosage forms including immediate release tablets, sustained release capsules, oral liquids, and sterile parenterals.
Developing and validating precise analytical methods for impurity profiling, forced degradation studies, and stability testing under ICH conditions.
Innovating non-infringing synthetic routes for bulk active pharmaceutical ingredients, optimizing yields, and ensuring cost-effective production.
Investigating targeted drug delivery platforms, nanotechnology-enabled formulations, and pediatric/geriatric friendly dosage options.
Our R&D center integrates formulation laboratories, pilot production bays, and high-containment analytical labs. The facility operates under strict Good Laboratory Practices (GLP) and supports seamless technology transfer from bench-scale research to full commercial production.
Looking for contract research, formulation co-development, or analytical method validation? Partner with our R&D team.
Inquire for R&D Collaboration